Dr David Griffiths
Managing Director, Pharma & Health Solutions
Dr David Griffiths heads up our Drug Development Solutions (DDS) business. With operational sites in the UK, Germany and the US, DDS provides bioanalytical, CMC analytical and therapeutic oligonucleotide discovery, development and manufacturing solutions for biotech and pharmaceutical clients around the world. In addition, David leads strategy development and the commercial team for Health Science & Innovation.
Prior to joining LGC, David was appointed Executive Director of HFL in 2005 (acquired by LGC in 2010) and was a founding member of Quotient Bioresearch in 2007. David moved to LGC in 2013 when LGC acquired the leading bioanalytical business from Quotient Bioresearch in December 2012.